![](/img/cover-not-exists.png)
Estimating the Budget Impact of Switching from Bortezomib Intravenous (Iv) to Bortezomib Subcutaneous (Sq) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Mexico
Wehler, EA, Kowal, S, Hernandez-Garduno, A, Danese de los Santos, L, de Anda, JA, Anaya, P, Munakata, J, Gonzalez, LVolume:
18
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.244
Date:
November, 2015
File:
PDF, 51 KB
2015